Sample ID | Age (years) | Sex | Bacterial isolation | Antibiotherapy before blood collection | Underlying diseases | Survival |
---|---|---|---|---|---|---|
Other sepsis (n = 13) | Â | Â | Â | Â | Â | Â |
   I001* | 52 | Male | Streptococcus non-group A or B | Ceftriaxone | - | Non-survivor |
   I002†‡ | 52 | Female | A. baumannii | Ceftazidime, bactrim | T2D, CRF, lung edema | Survivor |
   I004* ‡ | 45 | Male | Salmonella serotype B | Cloxacillin, ceftriaxone | T2D, arthritis | Survivor |
   I006* § | 37 | Male | C. albicans | Ceftriaxone, sulperazone, bactrim | HIV infection, tuberculosis | Survivor |
   I007* | 73 | Female | Corynebacterium spp. | - | NSAID-induced GI bleeding | Non-survivor |
   I008†¶ | 70 | Female | E. coli | Bactrim, ceftazidime | T2D | Survivor |
   I009* | 52 | Female | S. aureus | Ceftazidime, cloxacillin | T2D, knee abscess | Survivor |
   I010†‡¥ | 72 | Female | E. coli | Ceftriaxone | T2D, CRF | Survivor |
   I011* ¶ | 38 | Female | E. coli | - | HCV infection | Survivor |
   I012* § | 69 | Female | C. albicans | Ceftazidime | RF | Survivor |
   I013* | 74 | Female | Corynebacterium spp. | Ceftazidime, clarithromycin | Chronic heart failure, COPD | Survivor |
   I014* | 54 | Female | Salmonella spp. | Ceftriaxone, ceftazidime, levofloxacin | T2D, endometrial cancer, ITP | Survivor |
   I015* § | 41 | Male | C. albicans | Ceftazidime | HIV infection | Survivor |
Septicemic melioidosis (n = 11) | Â | Â | Â | Â | Â | Â |
   M001* | 68 | Male | B. pseudomallei | Ceftazidime, bactrim | Chronic heart failure, COPD | Non-survivor |
   M002* | 43 | Female | B. pseudomallei | Ceftriaxone, ceftazidime | T2D | Survivor |
   M003* | 55 | Male | B. pseudomallei | Ceftazidime | - | Non-survivor |
   M006* | 46 | Male | B. pseudomallei | Ceftriaxone | T2D, chirrosis | Non-survivor |
   M007* | 50 | Male | B. pseudomallei | Ceftazidime, tazocin | Lung cancer | Survivor |
   M008* | 70 | Female | B. pseudomallei | Ceftazidime, bactrim | T2D | Non-survivor |
   M009* | 48 | Female | B. pseudomallei | Sulperazone | T2D | Survivor |
   M010* | 48 | Male | B. pseudomallei | Ceftriaxone, ceftazidime, doxycycline | T2D | Survivor |
   M012* | 56 | Male | B. pseudomallei | Sulperazone, bactrim, cetazidime | T1D, ARF | Survivor |
   M014* | 65 | Female | B. pseudomallei | Cloxacilin, ceftazidime | T2D, chirrosis | Non-survivor |
   M015* | 41 | Male | B. pseudomallei | Bactrim, ceftazidime | - | Survivor |